fashion -WSS

fashion

author：comprehensive 2025-09-30 22:08:55 - browse：5737

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： HHS names first

hotspot

WSS

European regulators recommend Amylyx's ALS drug be rejected

Cancer cells are shown to suck energy source from immune cells

There’s no way to know how good AI health technologies are

Risky weight loss products often used by teens globally, per study

Humana CEO Bruce Broussard to step down in 2024

New Medicare drug pricing powers could soon be upended in court

knowledge

fashion

Wikipedia

Hollywood unions extend contract negotiations for actors

HHS names first

The cancer drug shortage isn’t new — and neither are the solutions

As JPM 2024 winds down, some health tech firms project optimism

Medicare details structure of new drug price negotiation program

Takeaways from AdvaMed, the largest medical devices conference

As demand for Covid shots wanes, Moderna seeks its next success

Caregivers of transplant patients call for more support, training

Anesthesiologist group: stop taking Ozempic before surgery

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

knowledge

Medicare to cover more brain scans related to Alzheimer’s drugs

European regulators recommend Amylyx's ALS drug be rejected

Peter Marks talks Operation Warp Speed for Rare Diseases

How doctors and nurses shape Google's AI

What's changing in Medicare's open enrollment this year?

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

focus

leisure time

hotspot

hotspot